Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway

Ziyuglycoside II is an active compound of Sanguisorba officinalis L. that has anti-inflammation, antioxidation, antibiosis, and homeostasis properties. We report here on the anticancer effect of ziyuglycoside II on human gastric carcinoma BGC-823 cells. We investigated the effects of ziyuglycoside II on cell growth, cell cycle, and cell apoptosis of this cell line. Our results revealed that ziyuglycoside II could inhibit the proliferation of BGC-823 cells by inducing apoptosis but not cell cycle arrest, which was associated with regulation of Bax/Bcl-2 expression, and activation of the caspase-3 pathway. Our study is the first to report the antitumor potential of ziyuglycoside II in BGC-823 gastric cancer cells. Ziyuglycoside II may become a potential therapeutic agent against gastric cancer in the future.

[1]  A. Ristimäki,et al.  Targeted therapy in gastric cancer , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  S. Z. Bathaie,et al.  Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells. , 2013, DNA and cell biology.

[3]  Xin Liu,et al.  Isolation and Identification of the Phenolic Compounds from the Roots of Sanguisorba officinalis L. and Their Antioxidant Activities , 2012, Molecules.

[4]  F. Wang,et al.  Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L. , 2012, International journal of biological macromolecules.

[5]  Sung-Dae Cho,et al.  Methanol extract of Sanguisorba officinalis L. with cytotoxic activity against PC3 human prostate cancer cells. , 2012, Molecular medicine reports.

[6]  V. Jendrossek.  The intrinsic apoptosis pathways as a target in anticancer therapy. , 2012, Current pharmaceutical biotechnology.

[7]  F. Han,et al.  Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis , 2012, Expert opinion on therapeutic targets.

[8]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  C. Cotman,et al.  Caspase-3 activation as a bifurcation point between plasticity and cell death , 2012, Neuroscience Bulletin.

[10]  R. Gill,et al.  Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity , 2011, Journal of surgical oncology.

[11]  B. B. Mishra,et al.  Natural products: an evolving role in future drug discovery. , 2011, European journal of medicinal chemistry.

[12]  George Lewith,et al.  Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review , 2010 .

[13]  M. Shah,et al.  Advanced gastric cancer--slow but steady progress. , 2010, Cancer treatment reviews.

[14]  Mee-Young Lee,et al.  Anti-asthmatic effect of Sanguisorba officinalis L. and potential role of heme oxygenase-1 in an ovalbumin-induced murine asthma model. , 2010, International journal of molecular medicine.

[15]  George Lewith,et al.  Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review. , 2010, Lung cancer.

[16]  D. Fan,et al.  New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives. , 2010, Future oncology.

[17]  B. Zhivotovsky,et al.  Mitochondrial targeting of tBid/Bax: a role for the TOM complex? , 2009, Cell Death and Differentiation.

[18]  A. Molassiotis,et al.  A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. , 2009, Complementary therapies in medicine.

[19]  G. Eslick,et al.  Traditional Chinese medicinal herbs in the treatment of patients with esophageal cancer: a systematic review. , 2009, Gastroenterology clinics of North America.

[20]  Y. H. Kim,et al.  Anti-Wrinkle Activity of Ziyuglycoside I Isolated from a Sanguisorba officinalis Root Extract and Its Application as a Cosmeceutical Ingredient , 2008, Bioscience, biotechnology, and biochemistry.

[21]  D. Fan,et al.  Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges , 2007, Expert review of anticancer therapy.

[22]  K. Yeoh.  How do we improve outcomes for gastric cancer? , 2007, Journal of gastroenterology and hepatology.

[23]  S. Joos,et al.  The role of Bcl-2 family members in tumorigenesis. , 2004, Biochimica et biophysica acta.

[24]  D. Hockenbery,et al.  Targeting Bcl-2 Related Proteins in Cancer Therapy , 2003, Cancer biology & therapy.

[25]  S. Nakashima,et al.  Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells , 2000, Cell Death and Differentiation.

[26]  John Calvin Reed,et al.  Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. , 1994, Oncogene.